Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggest a limited set of immunodominant sarcoma antigens

International Journal of Cancer

Volumn 72, Issue 3, 1997, Pages 403-407

  Heike, Michael ^a   Duchmann, Rainer ^a   May, Ekkehard ^a   Schulze Bergkamen, Henning ^a   Schmitt, Ute ^a   Meyer Zum Büschenfelde, Karl Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN; SARCOMA ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; PRIORITY JOURNAL; SARCOMA; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; FETAL BLOOD; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MELANOMA; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SARCOMA; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030790721     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970729)72:3<403::AID-IJC5>3.0.CO;2-T     Document Type: Article

References (25)

1. ARGAET, V.R. SCHMIDT, C.W., BURROWS, S.R., SILINS, S.L., KURILLA, M.G., DOOLAN, D.L., SUHRBIER, A., MOSS, D.J., KIEFF, E., SCULLEY, T.B. and MISKO, I.S., Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. exp. Med., 180, 2335-2340 (1994).
2. BOITEL, B., ERMONVAL, M., PANINA BORDIGNON, P., MARIUZZA, R.A., LANZAVECCHIA, A. and ACUTO, O., Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J. exp. Med., 175, 765-777 (1992).
3. CASANOVA, J.L. and MARYANSKI, J.L., Antigen-selected T-cell receptor diversity and self-nonself homology [see comments]. Immunol. Today, 14, 391-394 (1993).
4. DUCHMANN, R., MAY, E., ACKERMANN, B., GOERGEN, B., MEYER ZUM BÜSCHENFELDE, K.H. and MÄRKER HERMANN, E., HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or selfantigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand. J. Immunol., 43, 101-108 (1996).
5. ESPEVIK, T. and NISSEN-MEYER, J., A highly sensitive cell line. WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95, 99-105 (1986).
6. GARCIA, K.C., DEGANO, M., STANFIELD, R.L., BRUNMARK, A., JACKSON, M.R., PETERSON, P.A., TEYTON, L. and WILSON, I.A., An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science, 274, 209-219 (1996).
7. HAFLER, D.A., SAADEH, M.G., KUCHROO, V.K., MILFORD, E. and STEINMAN, L., TCR usage in human and experimental demyelinating disease. Immunol. Today, 17, 152-159 (1996).
8. HANSEN, M.B., NIELSEN, S.E. and BERG, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 95, 99-105 (1989).
9. + HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens. J. Immunol., 156, 2205-2213 (1996).
10. HOPP, T.P. and WOODS, K.R., Prediction of protein antigenic determinants from amino acid sequences. Proc. nat. Acad. Sci. (Wash.), 78, 3824-3828 (1981).
11. HOWELL, M.D., DIVELEY, J.P., LUNDEEN, K.A., ESTY, A., WINTERS, S.T., CARLO, D.J. and BROSTOFF, S.W., Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc. nat. Acad. Sci. (Wash.), 88, 10921-10925 (1991).
12. k determinant. Single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity. J. Immunol., 157, 2291-2298 (1996).
13. MACKENSEN, A., CARCELAIN, G., VIEL, S., RAYNAL, M.C., MICHALAKI, H., TRIEBEL, F., BOSQ, J. and HERCEND, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 1397-1402 (1994).
14. MAY, E., DUCHMANN, R., ACKERMANN, B., MEYER ZUM BÜSCHENFELDE, K.-H. and MÄRKER-HERMANN, E., TCR β junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptides display conserved hydropathy profiles in the absence of primary sequence homology. Int. Immunology, 8, 1815-1823 (1996).
15. PADOVAN, E., GIACHINO, C., CELLA, M., VALITUTTI, S., ACUTO, O. and LANZAVECCHIA, A., Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion. J. exp. Med., 181, 1587-1591 (1995).
16. PANNETIER, C., EVEN, J. and KOURILSKY, P., T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today, 16, 176-181 (1995).
17. PEOPLES, G.E., DAVEY, M.P., GOEDEGEBUURE, P.S., SCHOOF, D.D. and EBERLEIN, T.J., T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. J. Immunol., 151, 5472-1580 (1993).
18. ROMERO, P., PANNETIER, C., HERMAN, J., JONGENEEL, C.V., CEROITINI, J.C. and COULIE, P.G., Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J. exp. Med., 182, 1019-1028 (1995).
19. SENSI, M. and PARMIANI, G., Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today, 16, 588-595 (1995).
20. SENSI, M., SALVI, S., CASTELLI, C., MACCALLI, C., MAZZOCCHI, A., MORTARINI, R., NICOLINI, G., HERLYN, M., PARMIANI, G. and AMCHINI, A., T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. exp. Med., 178, 1231-1246 (1993).
21. SENSI, M. and 14 OTHERS, Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/ MART-1. Proc. nat. Acad. Sci. (Wash.), 92, 5674-5678 (1995).
22. SHILYANSKY, J., NISHIMURA, M.I., YANNELLI, J.R., KAWAKAMI, Y., JACKNIN, L.S., CHARMLEY, P. and ROSENBERG, S.A., T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. nat. Acad. Sci. (Wash.), 91, 2829-2833 (1994).
23. + T cells in cancer immunotherapy. Curr. Opin. Immunol., 6, 741-745 (1994).
24. TOYONAGA, B., YOSHIKAI, Y., VADASZ, V., CHIN, B. and MAK, T.W., Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc. nat. Acad. Sci. (Wash.), 82, 8624-8628 (1985).
25. TUNNACLIFFE, A., KEFFORD, R., MILSTEIN, C., FORSTER, A. and RABBITTS, T.H., Sequence and evolution of the human T-cell antigen receptor beta-chain genes. Proc. nat. Acad. Sci. (Wash.), 82, 5068-5072 (1985).